skip to main content

A phase II study of afatinib (BIBW 2992), an irreversible ErbB family blocker, in patients with HER2-positive metastatic breast cancer progressing after trastuzumab

Lin, Nancy ; Winer, Eric ; Wheatley, Duncan ; Carey, Lisa ; Houston, Stephen ; Mendelson, David ; Munster, Pamela ; Frakes, Laurie ; Kelly, Steve ; Garcia, Agustin ; Cleator, Susan ; Uttenreuther-Fischer, Martina ; Jones, Hilary ; Wind, Sven ; Vinisko, Richard ; Hickish, Tamas

Breast Cancer Research and Treatment, 2012, Vol.133(3), pp.1057-1065 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por

Identifique-se para postar sua resenha

Identifique-se para adicionar novas tags

Buscando em bases de dados remotas. Favor aguardar.